So, the hypothesis of AMA study is that the pre-treatment values of Hb and other erythrocyte indices have low power to predict the functional iron-deficiency in pregnancy and to discriminate iron-sufficient from iron-deficient pregnant women (potentially responsive to iron-therapy). This evidence concerns the gene GSTM1 and Iron deficiency anemia.